María Luisa Villanueva‐Peñacarrillo

Author

Hospital Universitario Fundación Jiménez Díaz

Also Known As

F. Reimann, J. J. Holst, M L Villanueva-Penacarrillo, M L Villanueva-Peñacarrillo, M. L. VILLANUEVA‐PEÑACARRILLO, M. L. Villanueva-Penacarrillo, M. L. Villanueva-Peñacarrillo, M. L. Villanueva‐Peñacarrillo, M. Villanueva-Peñacarrillo, M.L. Villanueva-Peñacarrillo

127

Publications

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Fundación Jiménez Díaz Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas Instituto de Salud Carlos III Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable

About

María Luisa Villanueva‐Peñacarrillo is an author at Hospital Universitario Fundación Jiménez Díaz specializing in medicine, physiology, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	30	1.8K
2	Health Sciences	14	19	774
3	Biochemistry	11	13	519
4	Natural Sciences	3	3	229
5	Biomedical Engineering	1	1	29

María Luisa Villanueva‐Peñacarrillo

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms Neşe I ̇meryüz, Berrak Ç. Yeğen, Ayhan Bozkurt, American Journal of Physiology-Gastrointestinal and Liver Physiology Gastrointestinal PharmacologyGastric FunctionImmunologyGastroenterologyDigestive Tract	1997	422
Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States Bernardo Nuche‐Berenguer, Paola Moreno, Pedro Esbrit, Calcified Tissue International Bone HealthGlp-1 TreatmentInsulin ManagementPhysiologyDiabetes	2009	188
Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states Bernardo Nuche‐Berenguer, Paola Moreno, Sergio Portal‐Núñez, Regulatory Peptides Metabolic SyndromeInsulin SignalingSclerostinBone Morphogenic ProteinDiabetic States	2009	141
Presence of a functional receptor for GLP‐1 in osteoblastic cells, independent of the cAMP‐linked GLP‐1 receptor Bernardo Nuche‐Berenguer, Sergio Portal‐Núñez, Paola Moreno, Journal of Cellular Physiology	2010	141
Glucagon‐like peptide 1: A potent glycogenic hormone Isabel Valverde, Mónica Morales, F. Clemente, FEBS Letters	1994	134
Changes in Glucagon-like Peptide-1 (GLP-1) Secretion after Biliopancreatic Diversion or Vertical Banded Gastroplasty in Obese Subjects Isabel Valverde, Jesús Puente, Antonio Martín‐Duce, Obesity Surgery ObesityMetabolic SyndromeBariatric SurgerySleeve GastrectomyMedicine	2005	113
Effect of GLP-1 on Lipid Metabolism in Human Adipocytes María Luisa Villanueva‐Peñacarrillo, Luis Márquez, Nieves González, Hormone and Metabolic Research	2001	106
Effect of GLP-1 Treatment on GLUT2 and GLUT4 Expression in Type 1 and Type 2 Rat Diabetic Models María Luisa Villanueva‐Peñacarrillo, Jesús Puente, Araceli Redondo, Endocrine Type 1Diabetes ManagementGlp-1 TreatmentInsulin ManagementPhysiology	2001	94
GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia Bernardo Nuche‐Berenguer, Daniel Lozano, Irene Gutiérrez-Rojas, Journal of Endocrinology	2011	90
Presence and characterization of glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of rat adipose tissue. Isabel Valverde, Elena Mérida, Elena Delgado, Endocrinology Rat Adipose TissueHalf-maximal BindingMolecular PhysiologyBiochemistryAmide Receptors	1993	87

Page 1